The role of Rasaushadhies in the management of Srotosanga w.s.r to Atherosclerotic Vascular disease
Abstract
The rapid pace of modern living, coupled with poor lifestyle choices and environmental factors, has contributed significantly to the growing prevalence of Srotorodha (atherosclerotic vascular disease). In Ayurveda, maintaining a balance of Dosha, Dhatu, Mala and Agni is key to a healthy life. This balance is achieved through the continuous transport and circulation of these elements via the Srotas, the body's internal transport system. These channels, which differ in size, are linked to various parts of the body and causes diseases when blocked. Atherosclerosis is a disease that is characterized by the accumulation of lipids, fibrous elements, and calcification within the large arteries. This process is initiated by endothelium activation, followed by a cascade of events, which implies the vessel narrowing and activation of inflammatory pathways leading to atheroma plaque formation. Atherosclerosis, the leading cause of cardiovascular diseases, primarily affects the heart and brain, resulting in ischemic heart disease (IHD) and ischemic stroke, which are the first and fifth leading causes of death worldwide, respectively. Srotosanga mentioned under Rasavaha Sroto Vikara is analogous to atherosclerotic vascular disease in modern medicine. In Ayurvedic practice the Rasaushadhies has been considered as more effective and beneficial due to lesser therapeutic doses, enhancement of action of other ingredients of formulation, more shelf life, quicker action and palatability as compared to herbal preparation. Rasaushadas which possess Kapha Medho hara, Lekhana Karma, Hridya, Ushna, Teekshna, Sukshma, Sara etc properties are useful in the management of atherosclerosis.
Downloads
References
Amir Ajoolabady, Pratico D, Lin L, Mantzoros CS, Suhad Bahijri, Tuomilehto J, et al. Inflammation in atherosclerosis: pathophysiology and mechanisms. Cell Death Dis [Internet]. 2024 Nov 11;15(11). Available from: https://www.nature.com/articles/s41419-024-07166-8
World Health Organization. The top 10 causes of death [Internet]. World Health Organization; 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
Zuo X, Ding X, Zhang Y, Kang YJ. Reversal of atherosclerosis by restoration of vascular copper homeostasis. Exp Biol Med. 2024;249:10185. doi: 10.3389/ebm.2024.10185
Agrawal K, Saley SR. Importance of srotodusti in ischemic heart disease and its management according to Ayurveda. [Details incomplete]
Gayathri H, Byresh A. Sroto vaigunya, sroto dushti and sroto viddha – a conceptual study. [Details incomplete]
Vagbhata A. Astanga Hridaya with commentaries of Sarvangasundara of Arunadatta and Ayurvedarasayana of Hemadri. Edited by Paradakara H. Varanasi: Chaukambha Krishnadas Academy; 2007. Sharirasthana, Chapter 3, verse 42. p. 393.
Akhigbe R, Ajayi A. The impact of reactive oxygen species in the development of cardiometabolic disorders: a review. Lipids Health Dis. 2021 Feb 27;20(1).
Shao B, Heinecke JW. HDL, lipid peroxidation, and atherosclerosis. J Lipid Res. 2009 Jan 12;50(4):599–601.
Tan M, Yin Y, Ma X, Zhang J, Pan W, Tan M, et al. Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis. Cell Death Dis [Internet]. 2023 Feb 16;14(2):1–19. Available from: https://www.nature.com/articles/s41419-023-05645-y
Subedi RP, Vartak RR, Kale PG. Modulation of oxidative stress by abhrak bhasma in Drosophila melanogaster. Asian J Pharm Clin Res [Internet]. 2018 May 1 [cited 2024 Dec 1];11(5):247–7. Available from: https://innovareacademics.in/journals/index.php/ajpcr/article/view/24472
Patil SG, Patil KA, Sarashetti R, Hadimur K. Effect of purified Shilajit (Asphaltum punjabianum) on oxidative stress, arterial stiffness and endothelial function in elderly with hypertension: a randomized controlled study. Indian J Physiol Pharmacol. 2023 Oct 10;67:197–204.
Sree Lakshmi KS, Nandagopalan G. Anticancer and immunomodulatory properties of herbomineral formulation abhrak bhasma on breast cancer. Indian J Pharm Sci [Internet]. 2024 Jan 1 [cited 2025 Jan 9];86(5). Available from: https://www.ijpsonline.com/articles/anticancer-and-immunomodulatory-properties-of-herbomineral-formulation-abhrak-bhasma-on-breast-cancer-5678.html
Kattoor AJ, Goel A, Mehta JL. LOX-1: regulation, signaling and its role in atherosclerosis. Antioxidants. 2019 Jul 11;8(7):218.
Nambiar S, Kadibagil VR, Hussain G. A review on therapeutic application of Swarnamakshika bhasma. J Biol Sci Opin [Internet]. 2017 Dec 10 [cited 2024 Dec 1];5(5):86–91. Available from: https://www.jbsoweb.com/admin/php/uploads/317_pdf.pdf
Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci. 2012 Nov 3;70(16):2859–72.
Kitamura N, Yokoyama Y, Taoka H, Nagano U, Hosoda S, Taworntawat T, et al. Iron supplementation regulates the progression of high fat diet induced obesity and hepatic steatosis via mitochondrial signaling pathways. Sci Rep [Internet]. 2021 May 24;11(1):10753. Available from: https://www.nature.com/articles/s41598-021-89673-8
Chien SJ, Chen TC, Kuo HC, Chen CN, Chang SF. Fulvic acid attenuates homocysteine-induced cyclooxygenase-2 expression in human monocytes. BMC Complement Altern Med [Internet]. 2015 Mar 13 [cited 2023 Feb 15];15(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369892/
Lan HT, Zheng YT, Tong ZJ, Zhang C, Cong XY, Wang ZH. Humic acids inhibit platelet activation to reduce venous thromboembolism in mice. Evid Based Complement Alternat Med. 2022 Dec 21;2022:1–9.
Dabravolski SA, Sukhorukov VN, Melnichenko AA, Khotina VA, Orekhov AN. The role of selenium in atherosclerosis development, progression, prevention and treatment. Biomedicines. 2023 Jul 17;11(7):2010–0.
Liu H, Xu H, Huang K. Selenium in the prevention of atherosclerosis and its underlying mechanisms. Metallomics. 2017 Jan 1;9(1):21–37.
Wechselberger C, Messner B, Bernhard D. The role of trace elements in cardiovascular diseases. Toxics. 2023 Nov 23;11(12):956–6.
Shen T, Zhao Q, Luo Y, Wang T. Investigating the role of zinc in atherosclerosis: a review. Biomolecules. 2022 Sep 23;12(10):1358–8.
Wang Y, Huang N, Yang Z. Revealing the role of zinc ions in atherosclerosis therapy via an engineered three-dimensional pathological model. Adv Sci. 2023 Apr 24;10(18).
Choi S, Liu X, Pan Z. Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases. Acta Pharmacol Sin [Internet]. 2018 Jul 1 [cited 2020 May 20];39(7):1120–32. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289396/
Kolluru GK, Shackelford RE, Shen X, Dominic P, Kevil CG. Sulfide regulation of cardiovascular function in health and disease. Nat Rev Cardiol [Internet]. 2023 Feb 1;20(2):109–25. Available from: https://www.nature.com/articles/s41569-022-00741-6
Seneff S, Davidson RM, Lauritzen A, Samsel A, Wainwright G. A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome. Theor Biol Med Model. 2015 May 27;12(1).
Gao Y, Wang B, Hu M, Ma Y, Zheng B. The role of iron in atherosclerosis and its association with related diseases. Curr Atheroscler Rep. 2024 Nov 9;27(1).
Naito Y, Masuyama T, Ishihara M. Iron and cardiovascular diseases. J Cardiol. 2021 Feb;77(2):160–5.
Wigren M, Bengtsson D, Duner P, Olofsson K, Bjorkbacka H, Bengtsson E, et al. Atheroprotective effects of alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells. Circ Res. 2009 Jun 19;104(12).
Ou L, Zhong S, Ou J, Tian J. Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis. Acta Pharmacol Sin. 2020 May 26.
Srivastava N, Paarakh P. Role of silver nanoparticles in the treatment of hyperlipidemia. Int J Novel Res Dev [Internet]. 2022 [cited 2024 Dec 5];7(7):47. Available from: https://www.ijnrd.org/papers/IJNRD2207006.pdf
Lv X, Zhao L, Song Y, Chen W, Tuo Q. Deciphering the role of copper homeostasis in atherosclerosis: from molecular mechanisms to therapeutic targets. Int J Mol Sci [Internet]. 2024 Oct 25 [cited 2024 Nov 8];25(21):11462–2. Available from: https://www.mdpi.com/1422-0067/25/21/11462
Kim BE, Nevitt T, Thiele DJ. Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol. 2008 Feb 15;4(3):176–85.
Fukai T, Ushio-Fukai M, Kaplan JH. Copper transporters and copper chaperones: roles in cardiovascular physiology and disease. Am J Physiol Cell Physiol. 2018 Aug 1;315(2):C186–201.
Festa RA, Thiele DJ. Copper: an essential metal in biology. Curr Biol [Internet]. 2011;21(21):R877–83. Available from: https://www.ncbi.nlm.nih.gov/pubmed/22075424
Uriu-Adams JY, Keen CL. Copper, oxidative stress, and human health. Mol Aspects Med. 2005 Aug;26(4–5):268–98.
Chen J, Jiang Y, Shi H, Peng Y, Fan X, Li C. The molecular mechanisms of copper metabolism and its roles in human diseases. Pflugers Arch. 2020 Jun 7;472(10):1415–29.
Maung MT, Carlson AK, Olea-Flores M, Elkhadragy L, Schachtschneider KM, Navarro-Tito N, et al. The molecular and cellular basis of copper dysregulation and its relationship with human pathologies. 2021 Aug 14;35(9).
Zuo X, Ding X, Zhang Y, Kang YJ. Reversal of atherosclerosis by restoration of vascular copper homeostasis. Exp Biol Med [Internet]. 2024 Jun 24 [cited 2024 Aug 20];249. Available from: https://pubmed.ncbi.nlm.nih.gov/38978540/
Omata D, Munakata L, Maruyama K, Suzuki R. Ultrasound and microbubble-mediated drug delivery and immunotherapy. J Med Ultrason. 2022 Apr 11.
Kulkarni DA. Rasa Ratna Samuchchya. Drayaganj, New Delhi: Meharchand Lachhmandas Publication; 1998. p. 94.
[Author missing]. Study of Vanga Bhasma antihyperlipidaemic activity in Wistar albino rats - an experimental study. World J Pharm Med Res [Internet]. 2015 [cited 2024 Dec 5];2021(July issue 8). Available from: https://www.wjpmr.com/home/article_abstract/3686
Nille G, Gupta LN. Historical review of lead (Pb)-based ancient Ayurvedic medicine Naga Bhasma. [Internet]. 2022 [cited 2024 Dec 5];10(11):2320–882. Available from: https://ijcrt.org/papers/IJCRT2211612.pdf
Jagtap CY, Prajapati P. Therapeutic potentials of metals in ancient India: a review through Charaka Samhita. J Ayurveda Integr Med [Internet]. 2014 Mar 24 [cited 2024 Dec 6];2(2):55. Available from: https://www.academia.edu/6533323/Therapeutic_potentials_of_metals_in_ancient_India_A_review_through_Charaka_Sam
Ghildiyal R, Mitra S, Sharma U, Chand Sharma K. Pittala and its formulations: a review. Int Ayurvedic Med J [Internet]. 2023 May 31 [cited 2024 Dec 6];7(4):340–6. Available from: https://www.iamj.in/current_issue_print/images/upload/340_346_1.pdf
Gopan Y, Kamath TS. Ayurvedic management of dyslipidemia – a conceptual analysis. Int Ayurvedic Med J. 2024 Jan 14;12(1):237–42.
Ambikadatta S. Sushruta Samhita, Ayurveda Tatva Sandeepika – Hindi Vyakhya. Varanasi: Chowkhamba Sanskrit Sansthan; 221005;1(7):11.
Dudek Ł, Kochman W, Dziedzic E. Silicon in prevention of atherosclerosis and other age-related diseases. Front Cardiovasc Med. 2024 Mar 1;11.
